Tencent-backed digital analytics software provider Amplitude has reportedly filed confidentially for a direct listing, weeks after raising cash at a $4bn valuation.

Ionis Pharmaceuticals' stake in the muscular disease treatment developer will be cut in an offering set to raise between $95m and $107m.

The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.

General Motors, Hyundai, Kia, Geely, SAIC Motor, Koch Industries, Foxconn and LG took part in a $200m PIPE supporting a $3.6bn reverse merger for lithium-metal battery developer SES.

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

The digital wallet developer’s $255m IPO would allow Cisco, GMO, American Express, Bajaj Finance, MediaTek, Net1 and New Delhi Television to exit.

Alphabet, GeneScience, AstraZeneca, Shire, Novartis, Ping An, KPC and Stevanato are in line for exits after the drug delivery technology developer filed to go public.

The Boston Scientific-backed medical device maker has filed to raise up to $100m in an offering on the Nasdaq Global Market.

The GV-backed heart disease treatment developer intends to go public this year having secured $248m in venture funding.

Block.one's blockchain technology spinoff is joining forces with publicly listed Far Peak Acquisition Corporation at a $9bn valauation.